These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 21548727)

  • 21. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
    Kaialy W; Martin GP; Ticehurst MD; Momin MN; Nokhodchi A
    Int J Pharm; 2010 Jun; 392(1-2):178-88. PubMed ID: 20363301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension.
    Shahin HI; Vinjamuri BP; Mahmoud AA; Shamma RN; Mansour SM; Ammar HO; Ghorab MM; Chougule MB; Chablani L
    J Control Release; 2019 May; 302():126-139. PubMed ID: 30940497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting.
    Nasr M; Awad GA; Mansour S; Taha I; Al Shamy A; Mortada ND
    Eur J Pharm Biopharm; 2011 Nov; 79(3):601-11. PubMed ID: 21827854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance.
    Zhong Q
    AAPS PharmSciTech; 2018 Feb; 19(2):531-540. PubMed ID: 28840529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of ciprofloxacin-loaded nano-and microcomposite particles for dry powder inhaler formulations: preparation, in vitro characterisation, and antimicrobial efficacy.
    Topal GR; Devrim B; Eryilmaz M; Bozkir A
    J Microencapsul; 2018 Sep; 35(6):533-547. PubMed ID: 30213209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S; Tros de Ilarduya C
    Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology.
    Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Mirzadeh H; Fakhari A; Nokhodchi A
    J Microencapsul; 2009 Feb; 26(1):1-8. PubMed ID: 18465287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Air permeability of powder: a potential tool for Dry Powder Inhaler formulation development.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2010 Nov; 76(3):464-9. PubMed ID: 20854906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate.
    Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP
    Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
    Kaialy W; Momin MN; Ticehurst MD; Murphy J; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Sep; 79(2):345-56. PubMed ID: 20537870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amoxicillin-bearing microparticles: potential in the treatment of Listeria monocytogenes infection in Swiss albino mice.
    Farazuddin M; Chauhan A; Khan RM; Owais M
    Biosci Rep; 2011 Aug; 31(4):265-72. PubMed ID: 20687896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of carrier particle shape on dry powder inhaler performance.
    Kaialy W; Alhalaweh A; Velaga SP; Nokhodchi A
    Int J Pharm; 2011 Dec; 421(1):12-23. PubMed ID: 21945739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration.
    Abdelbary AA; Al-mahallawi AM; Abdelrahim ME; Ali AM
    Int J Nanomedicine; 2015; 10():6339-53. PubMed ID: 26491298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.